Nanoparticle Drug Delivery Assay in Human Peripheral Blood Mononuclear Cells
To determine efficacy of nanoparticle-based drug delivery systems in human peripheral blood mononuclear cells (HPBMC).
Features of the assay
|
Detailed description
Nanoparticulate pharmaceutical drug delivery systems are widely used in pharmaceutical research and in clinical settings to enhance the effectiveness of diagnostic agents and drugs, including anticancer, antimicrobial and antiviral drugs [1]. We established a single-cell assay to evaluate kinetics of efficacy of nanoparticle-based delivery systems in primary human peripheral blood mononuclear cells taking advantage of live-cell imaging and time-lapse technology.
References